Consequently, the immunological impact of the new antidiabetic drugs (SGLT2i and GLP1-RAs) looks very relevant
S., Raju, R., Soumya, S
Nutrients 9:1 Meister R, von Wolff A, Mohr H, Harter M, Nestoriuc Y, Holzel L, Kriston L (2016) Comparative safety of pharmacologic treatments for persistent depressive disorder: a systematic review and network meta-analysis
#nasaldelivery #GenericInnovation #OffPatent #Semaglutide #Tirzepatide #Nasal #Inhalation #obesity #weighmanagement #Diabetes To view or add a comment, sign in Several drugs are known to cause hypomagnesemia, usually by increasing renal excretion, reducing intestinal absorption, or causing shifts into cells
The growing prevalence of obesity and associated comorbidities, such as diabetes and cardiovascular disorders, has propelled the demand for GLP-1 receptor agonists
,